Serina Therapeutics (SER) Other Working Capital Changes (2018 - 2025)
Serina Therapeutics (SER) posted Other Working Capital Changes of -$32000.0 for Q4 2025, up 36.0% sequentially from -$50000.0 in Q3 2025, and up 33.33% YoY from -$24000.0 in Q4 2024.
Serina Therapeutics (SER) Other Working Capital Changes (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Other Working Capital Changes for 5 years, with the latest figure at -$32000.0 in Q4 2025.
- Quarterly Other Working Capital Changes rose 33.33% year-over-year to -$32000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$187000.0 (up 12.62% YoY) and the FY2025 annual result came in at -$187000.0, up 12.62% from the prior year.
- Other Working Capital Changes improved to -$32000.0 in Q4 2025 per SER's latest filing, from -$50000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.6 million in Q2 2024 and troughed at -$766000.0 in Q3 2025.
- A 5-year average of -$23105.3 and a median of -$117000.0 in 2021 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes plunged 39.02% in 2024, then surged 33.33% in 2025.
- Over 3 years, Other Working Capital Changes stood at -$56000.0 in 2023, then increased by 14.29% to -$48000.0 in 2024, then jumped by 33.33% to -$32000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$32000.0, -$50000.0, and -$49000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 143,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Sep 30, 2025 | -766,000.00 |
| Sep 30, 2025 | -766,000.00 |
| Sep 30, 2025 | -766,000.00 |
| Jun 30, 2025 | 408,000.00 |
| Jun 30, 2025 | 408,000.00 |
| Jun 30, 2025 | 408,000.00 |
| Mar 31, 2025 | -458,000.00 |
| Mar 31, 2025 | -458,000.00 |
| Mar 31, 2025 | -458,000.00 |
| Dec 31, 2024 | -543,000.00 |
| Dec 31, 2024 | -543,000.00 |
| Dec 31, 2024 | -543,000.00 |
| Sep 30, 2024 | -230,000.00 |
| Sep 30, 2024 | -230,000.00 |
| Sep 30, 2024 | -230,000.00 |
| Jun 30, 2024 | 2.62 Mn |
| Jun 30, 2024 | 2.62 Mn |